Close Menu

NEW YORK (GenomeWeb) – Natera reported after the close of the market on Tuesday that its fourth quarter 2018 revenues grew 29 percent, beating Wall Street's expectations.

For the three months ended Dec. 31, 2018, Natera recognized $67.0 million in revenue compared to $52.0 million in Q4 2017. Analysts, on average, had anticipated Q4 2018 revenues of $64.0 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

May
21
Sponsored by
Qiagen

This webinar will provide a first-hand look at how a hematology/oncology lab in the UK set up and validated three molecular assays for routine in-house use.

Jun
17

This webinar will provide an overview of polygenic risk scores, which aggregate dozens of genetic variants that have been linked to disease risk in genome-wide association studies (GWAS) into a single score.

Jun
18
Sponsored by
ArcherDX

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect.